Diamedica Therapeutics Inc (DMAC)

Cash & Short-Term Investments

$43.50M

Quarterly · Period ending: · USD

DMAC logo

DMAC Cash & Short-Term Investments

Latest reported$43.50M
DMAC Quarterly Cash & Short-Term Investments ($274.76K → $43.50M)
High-resolution chart · PNG

DMAC cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Diamedica Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
43,504,000
51,331,000
59,890,000
55,318,000
30,038,000
36,320,000
44,147,000
50,197,000
54,055,000
46,516,000
52,895,000
46,465,000
40,368,000
28,655,000
33,502,000
36,084,000
38,443,000
41,047,000
45,112,000
48,097,000
21,295,000
23,401,000
27,507,000
30,623,000
11,799,000
12,648,000
7,878,000
9,743,000
10,966,000
13,717,000
16,823,000
3,900,626
5,661,402
6,718,661
1,353,000
857,735
1,530,227
938,520
1,736,361
2,963,788
365,228
333,429
165,692
140,034
458,192
267,886
203,785
486,466
1,249,145
1,470,520
2,521,199
1,065,009
2,079,713
4,337,585
2,339,746
3,885,302
3,917,175
2,074,605
2,651,971
3,851,975
1,774,638
2,403,354
2,836,770
481,532
155,676
337,897
629,526
1,079,448
1,443,044
1,891,793
2,467,888
3,162,515
2,706,699
3,347,300
3,501,580
3,742,639
4,237,194
4,229,584
269,603
197,008
274,764
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.